Accendra Health, Inc., along with its subsidiaries, is a leading nationwide provider of products, technology, and services that supports health beyond the hospital for millions of people each year. The company delivers a broad portfolio of home-based healthcare solutions, including diabetes care, sleep therapy, home respiratory therapy, ostomy supplies, wound care products, and urology supplies. Its core business focuses on serving patients in non-acute settings through direct-to-consumer and payor-supported channels.

Accendra Health generates revenue primarily from the sale of medical products and provision of healthcare services across multiple therapeutic categories. Revenue is derived from products such as glucose monitoring systems, continuous positive airway pressure (CPAP) devices, respiratory ventilators, ostomy pouches, advanced wound dressings, and urinary catheters. The company serves a diverse customer base including individual patients, commercial payors, government programs, and healthcare providers, with revenue streams supported by both direct sales and reimbursement from insurance entities.

As discussed within Note 1 in the Notes to Condensed Consolidated Financial Statements, the company's business activities comprise a single operating and reporting segment.

• Single Operating Segment: Accendra Health operates as one integrated segment focused on delivering products, technology, and services that support health beyond the hospital. This segment encompasses all of the company's core offerings across diabetes care, sleep therapy, home respiratory therapy, ostomy, wound care, and urology. The company markets its products under various brand names, including but not limited to Apria Direct and Byram Healthcare, which are trademarks associated with its home medical equipment and supply offerings.

Accendra Health holds a leading position as a nationwide provider of home-based healthcare products and services, competing in a fragmented industry with other national and regional durable medical equipment (DME) suppliers. Its competitive advantages stem from its integrated service model, broad product portfolio, and established relationships with payors and healthcare providers. The company differentiates itself through its technology-enabled care coordination and scale in managing complex patient populations across multiple therapy areas.

The company serves millions of patients annually across the United States, including individuals managing chronic conditions such as diabetes, sleep apnea, and respiratory disorders. Its customer base includes Medicare and Medicaid beneficiaries, commercially insured patients, and those receiving care through long-term care facilities and home health agencies. Specific payer relationships include contracts with national commercial health plans, though individual payer names are not disclosed in the filing.